1) tolypomycin Y
多利霉素Y
2) Maridomycin
[,mæridəu'maisin]
麦利多霉素
3) Lincomycin Hydrochloride and Lidocaine Hydrochloride Gel
林可霉素利多卡因凝胶
1.
Determinate of Lincomycin Hydrochloride and Lidocaine Hydrochloride in Lincomycin Hydrochloride and Lidocaine Hydrochloride Gel by HPLC;
HPLC法同时测定林可霉素利多卡因凝胶中林可霉素和盐酸利多卡因的含量
4) compound lidocaine and chloramphenicol
利多卡因氯霉素复合液
1.
AIM To study compound lidocaine and chloramphenicol continue washing in treatment eye METHODS 56 cases with 105 eyes bruned were received compound lidocaine and chloramphenicol continue washing treatment RESULTS The rate of effective was 92 3% CONCLUSION Local washing treatment with compound lidocaine and chloramphenicol was satisfactory and easy method to treat eye burn
目的 观察利多卡因氯霉素复合液持续结膜囊冲洗治疗眼烧伤的疗效。
5) telithromycin
泰利霉素
1.
A new process for preparation the ketolide antibiotic telithromycin by multistep reactions started from clarithromycin is reported.
以克拉霉素为原料,经多步反应制得酮内酯类抗生素泰利霉素。
2.
4-[4-(3-Pyridinyl)-1H-imidazol-1-yl]-1-butanamine, the side chain of telithromycin, was synthesized from 3-acetylpyridine via bromation, cyclization, condensation with N-(4-bromobutyl)phthalimide and hydrazinolysis with an overall yield of 31%.
3-乙酰吡啶经溴化、环合得4-(3-吡啶基)-1H-咪唑,再经与N-(4-溴丁基)邻苯二甲酰亚胺缩合和肼解得到泰利霉素的重要中间体4-[4-(3-吡啶基)-1H-咪唑基]-1-丁胺,总收率为31%。
3.
The mechanism of acquired macrolide resistance,the structureactivity relationships of ketolides and clinical properties of cethromycin (ABT-773) and telithromycin are mainl.
现综述大环内酯的获得性耐药机制,进而阐明以大环内酯为基础经结构改造而来的酮内酯类抗生素的构效关系,并介绍其代表性药物泰利霉素和喹红霉素(ABT-773)的临床特性。
6) rifamycin
[英][,rifə'maisin] [美][,rɪfə'maɪsɪn]
利福霉素
1.
Biological Treatment for Rifamycin Wastewater;
利福霉素生产废水的生物处理
2.
Study of the Screening on the Rifamycin-Producing Strains with the Ion Implantation;
离子注入利福霉素产生菌诱变选育研究
3.
Determination of Rifamycin by Rp—HPLC;
HPLC法测定利福霉素含量
补充资料：多利霉素Y
分子式：
CAS号：
性质：又称颗粒霉素。是与利福霉素B,O等同时由链霉菌Streptomyces tolypophorus产生的安莎类抗生素。黄色针状结晶。300℃以下无明确熔点。易溶于甲醇、乙醇、丙酮，微溶于水。旋光度[α]D21+376°(c=0.5，丙酮)，紫外吸收峰(ε):232nm(29 000)、290nm(23 800)，337nm(12 700)与337～430nm(肩)。具有抗革兰氏附性菌与抑制痘苗病毒作用。
CAS号：
性质：又称颗粒霉素。是与利福霉素B,O等同时由链霉菌Streptomyces tolypophorus产生的安莎类抗生素。黄色针状结晶。300℃以下无明确熔点。易溶于甲醇、乙醇、丙酮，微溶于水。旋光度[α]D21+376°(c=0.5，丙酮)，紫外吸收峰(ε):232nm(29 000)、290nm(23 800)，337nm(12 700)与337～430nm(肩)。具有抗革兰氏附性菌与抑制痘苗病毒作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条